Central Pharma shares soar 32% in five days | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Wednesday
July 23, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
WEDNESDAY, JULY 23, 2025
Central Pharma shares soar 32% in five days

Stocks

TBS Report
04 August, 2021, 09:55 pm
Last modified: 04 August, 2021, 10:01 pm

Related News

  • Why Bangladesh's capital market is poised for a bull run
  • Dhaka Bank’s former chairman to receive 1.03cr shares as gift from sister
  • DSEX breaks past 5,200 after 3-month lull, turnover hits 8-month high
  • DSE inspection finds RSRM Steel factory closed, but share price surges
  • Stocks jump, turnover reaches Tk700cr mark after 8 months

Central Pharma shares soar 32% in five days

The share price increased to Tk19.5 each on Monday, from Tk14.7 on 27 July

TBS Report
04 August, 2021, 09:55 pm
Last modified: 04 August, 2021, 10:01 pm
Central Pharma shares soar 32% in five days

The share price of Central Pharmaceuticals Ltd rose 32% in just five trading sessions on the Dhaka Stock Exchange (DSE) without any price-sensitive information.

The share price increased to Tk19.5 each on Monday, from Tk14.7 on 27 July.

For this unusual price hike, the country's premier bourse sent a query to the company on 2 August.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

In its reply, the company said there is no undisclosed price sensitive information for this recent price hike and the increase in volumes of shares.

Following this, the share price dropped 3.5% on Tuesday.

During the pandemic, most of the country's drugmakers have registered significant growth in revenue and profit but remarkably the Central Pharmaceuticals had incurred huge losses in fiscal 2019-2020.

As the company fell into losses, its shareholders did not get any dividends.

The company said in its financials due to pandemic and temporary factory closure by the Directorate General of Drug Administration, its net turnover decreased 54.44% to stand at Tk14.01 crore, from Tk30.74 crore in the previous fiscal year.

While the company had incurred a loss of Tk110.70 crore in fiscal 2019-2020, its net profit was Tk5.70 crore in the previous fiscal year.

After the blow in the last fiscal year, the company returned to profit in the first half of fiscal 2020-2021.

In the July-December period, the company reported a profit but, in the January-March quarter, it fell into losses.

In the first nine months of fiscal 2020-2021, its net turnover stood at Tk13.94 crore, the profit at Tk73 lakh, and the earnings per share (EPS) at Tk0.06.

At the corresponding period of the previous year, it had incurred a loss of Tk84 lakh and the loss per share stood at Tk0.07.

In the July-December period, its turnover was Tk12.11 crore and the profit stood at Tk1.95 crore.

But in the January-March quarter, it incurred a loss of Tk1.22 crore and the loss per share stood at Tk0.10 while the loss per share was Tk0.18 in the corresponding period of the previous fiscal year.

Central Pharmaceuticals Ltd was listed on local stock exchanges in 2013.

As of June 2021, sponsors and directors held 25.89%, institutional investors 16.96% and general shareholders 57.15% shares of the company.

Central Pharma / DSE

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Photo: CA Press Wing
    Stronger stance needed on maintaining law and order: Political parties to CA
  • Photo: Syed Zakir Hossain/TBS
    Secretariat protest: 75 injured in police-protester clash over edu adviser's resignation for delaying HSC rescheduling
  • Bangladesh win nail-biter to clinch series win 
    Bangladesh win nail-biter to clinch series win 

MOST VIEWED

  • Screengrab/Video collected from Facebook
    CCTV footage shows how Air Force jet nosedived after technical malfunction
  • ISPR clarifies crashed plane was battle aircraft, not training jet
    ISPR clarifies crashed plane was battle aircraft, not training jet
  • The jet plane charred after crash on 21 July at the Milestone school premises. Photo: Mehedi Hasan/TBS
    Milestone plane crash: Death toll rises to 31 as nine more succumb to injuries
  • Students and police clash at Milestone School and College on 22 July 2025. Photo: TBS
    Protesting Milestone students clash with police, besiege law and education advisers
  • Photo: Syed Zakir Hossain/TBS
    Secretariat protest: 75 injured in police-protester clash over edu adviser's resignation for delaying HSC rescheduling
  • Aerial view of the Milestone school premises where the crash took place on 21 July. Photo: Olid Ebna Shah/ TBS
    ‘Why here?’: Concerns expressed over airbase inside city

Related News

  • Why Bangladesh's capital market is poised for a bull run
  • Dhaka Bank’s former chairman to receive 1.03cr shares as gift from sister
  • DSEX breaks past 5,200 after 3-month lull, turnover hits 8-month high
  • DSE inspection finds RSRM Steel factory closed, but share price surges
  • Stocks jump, turnover reaches Tk700cr mark after 8 months

Features

Photo: Mehedi Hasan/TBS

Aggrieved nation left with questions as citizens rally to help at burn institute

8h | Panorama
Photo: TBS

Mourning turns into outrage as Milestone students seek truth and justice

2h | Panorama
Illustration: TBS

Uttara, Jatrabari, Savar and more: The killing fields that ran red with July martyrs’ blood

1d | Panorama
Despite all the adversities, girls from the hill districts are consistently pushing the boundaries to earn repute and make the nation proud. Photos: TBS

Ghagra: Where dreams rise from dust for Bangladesh women's football

2d | Panorama

More Videos from TBS

What information did the director of the NBPSI give about the admitted patients?

What information did the director of the NBPSI give about the admitted patients?

1h | TBS Today
What is discussed at the Chief Advisor's meeting?

What is discussed at the Chief Advisor's meeting?

1h | TBS Today
Two advisors and press secretary were blocked at Milestone for 8 hours

Two advisors and press secretary were blocked at Milestone for 8 hours

1h | TBS Today
Chief advisor's meeting with 4 parties; what was discussed?

Chief advisor's meeting with 4 parties; what was discussed?

2h | TBS Today
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net